Janus kinase inhibitors may be an effective treatment to reduce skin depigmentation in vitiligo
Autor: | Shannon E. Lohman |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
business.industry General Engineering Vitiligo medicine.disease Dermatology 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Depigmentation 030220 oncology & carcinogenesis medicine General Earth and Planetary Sciences Effective treatment medicine.symptom business Janus kinase General Environmental Science |
Zdroj: | Clinical Research In Practice: The Journal of Team Hippocrates. 6 |
ISSN: | 2379-4550 |
DOI: | 10.22237/crp/1593561900 |
Popis: | A clinical decision report appraising Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. J Am Acad Dermatol.2017 Jun;76(6):1054-1060.e1. https://doi.org/10.1016/j.jaad.2017.02.049 for a patient with worsening vitiligo. |
Databáze: | OpenAIRE |
Externí odkaz: |